879 filings
Page 23 of 44
8-K/A
ajmqxqta qvqur2zn4v
11 May 12
Departure of Directors or Certain Officers
12:00am
8-K
gxqlso7fjy4oa
10 May 12
Departure of Directors or Certain Officers
12:00am
8-K
1sre5
3 May 12
Discovery Labs Reports First Quarter 2012 Financial Results
12:00am
S-8
49x58i86dr3966e072gc
30 Mar 12
Registration of securities for employees
12:00am
8-K
vicbwrda
29 Mar 12
Discovery Labs Reports Fourth Quarter Financial Results and Highlights Recent Milestones
12:00am
424B5
sa02tg
19 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
25ysmoisw7 9nxo
16 Mar 12
Discovery Labs Prices $45.0 Million Public Offering of
12:00am
424B5
ssvukk
15 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
h3k8804fdj41bl
7 Mar 12
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) for Prevention of Respiratory Distress Syndrome
12:00am
8-K
8kdpjlhqsa8yq1gb
8 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
1mrs0iaf
2 Feb 12
Other Events
12:00am
424B5
trx0v wul9tv
15 Dec 11
Prospectus supplement for primary offering
12:00am
8-K
jn93f
14 Dec 11
Entry into a Material Definitive Agreement
12:00am
8-K
83u5g2jx9ea0w83wpamc
10 Nov 11
Results of Operations and Financial Condition
12:00am
8-K
tevbo 36t
14 Oct 11
Departure of Directors or Certain Officers
12:00am
424B3
0wm99io3
12 Oct 11
Prospectus supplement
12:00am
8-K
u9y3 5o84d
3 Oct 11
Amendments to Articles of Incorporation or Bylaws
12:00am